骨微环境调节的生物材料可以促进骨硬化治疗
Hang Dong1, Tongtong Zhu1, Yirong Sun2
1Department of Traumatic Orthopedics, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, PR China.
Biomaterials
|December 31, 2025
概括
本综述探讨了治疗骨髓缩 (骨死亡) 的生物材料策略,重点是加强骨再生和血管化,同时控制免疫反应和骨再吸收.
科学领域:
- 生物材料科学 生物材料科学
- 整形外科的研究研究.
- 再生医学是一种再生医学.
背景情况:
- 骨髓缩包括血管损伤,骨细胞死亡和异常的骨重塑,导致关节恶化和疼痛.
- 目前的治疗方法,如骨移植,由于自身骨稀缺而面临局限性.
- 先进的生物材料为改善骨髓缩治疗提供了潜力.
研究的目的:
- 系统地审查目前基于生物材料的骨髓缩治疗策略.
- 突出血管再生和骨质生成的创新方法.
- 讨论生物材料制造,机制和生物活性材料的未来趋势.
主要方法:
- 系统的文献综述 关于骨髓折的生物材料.
- 分析增强血管化,骨质生成和免疫调节的策略.
- 生物材料制造和组织再生机制的概述.
主要成果:
- 生物材料可以促进血管再生和骨形成.
- 现有策略可以抑制骨质细胞活动并调节免疫反应.
- 制造方法和生物活性材料的开发正在推进.
结论:
- 基于生物材料的疗法在骨硬化治疗方面表现有前途.
- 未来的研究应该专注于下一代生物材料,以增强组织再生.
- 多功能生物材料是解决复杂骨髓缩病理学的关键.
相关概念视频
01:31Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
01:40Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K